Celgene CEO on deal to acquire Impact Biomedicines - Dvolatility Market News

Breaking

Tuesday, January 9, 2018

Celgene CEO on deal to acquire Impact Biomedicines

Celgene CEO Mark Alles on the company's acquisition of Impact Biomedicines and the future of biotech and drug innovation.

(Source: Fox Business TV, January 9, 2018 at 10:50AM)

Comment Form is loading comments...